Western Oncolytics Raises $2.5M For Cancer Immunotherapy
News
Western Oncolytics recently announced it has raised $2.5 million through a Series A round of funding to invest in the development of its lead oncolytic drug, WO-12, a therapy designed to deliver multiple immunotherapies ... Read more